PRTODAY / NewswireToday Free press release distribution service network

Agency / Source: Bioo Scientific

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!

Bioo Scientific Launches A New Division - Bioo Therapeutics - Bioo Scientific launched Bioo Therapeutics to leverage their drug delivery vehicles and experience in antibody and small molecule research to develop therapeutic agents
Bioo Scientific Launches A New Division - Bioo Therapeutics

 

NewswireToday - /newswire/ - Austin, TX, United States, 11/11/2009 - Bioo Scientific launched Bioo Therapeutics to leverage their drug delivery vehicles and experience in antibody and small molecule research to develop therapeutic agents.

   
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

Bioo Therapeutics, a division of Bioo Scientific, was launched today to leverage Bioo Scientific’s proprietary drug delivery vehicles and extensive experience in antibody and small molecule research to use as a basis to develop therapeutic agents to combat cancer and other diseases. Bioo Therapeutics flagship drug delivery technology is a patent pending antibody conjugation technology which delivers small RNA drugs into specifically targeted cells or tissues. The scientists at Bioo Scientific have made significant strides in developing and using antibody-based agents for the directed delivery of short interfering RNAs by improving the loading capacity of antibody drug carriers and demonstrating their ability to successfully deliver small RNAs into tumors generated from cells expressing the cell surface target. Drugs or toxins can be attached to monoclonal antibodies which target a specific cell type forming monoclonal antibody conjugates. These monoclonal antibody conjugates are used as homing devices to deliver these substances directly into targeted cells. This patent pending technology can revolutionize the delivery of siRNA and other RNAi agents, as well as, other more traditional drugs.

"Bioo Therapeutics is actively seeking to partner with pharmaceutical companies or venture capitalists to make possible the therapeutic potential of this technology. This effort will advance targeted drug delivery which is vitally important for the development of new cures and treatments of cancer," said Lance Ford, VP of Research and Business Development for Bioo Scientific. This research is being supported by funding in part through grants from the National Science Foundation (NSF), the National Institute of Allergy and Infectious Disease (NIAID) and clients.

About Bioo Therapeutics
Bioo Therapeutics (biootherapeutics.com) is a division of Bioo Scientific, is an Austin, TX based biotechnology company that provides innovative solutions to the life science industry. Bioo Therapeutics was launched to leverage Bioo Scientific’s proprietary drug delivery vehicles and extensive experience in antibody and small molecule research to use as a basis to develop therapeutic agents to combat cancer and other diseases.

 
 


Rank or share this free Newswire Press Release Distribution content. Join the network! Learn How!


Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour.


 

Agency / Source: Bioo Scientific

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bioo Scientific Launches A New Division - Bioo Therapeutics

Non-featured company website links are shown on a random basis
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  For more information, please visit:
Links are available on a random basis for non premium members
|
Contact: Dawn Obermoeller 
512-301-4094 dawno[.]biooscientific.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bioo Scientific securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSS
AddThis press release: Bioo Scientific Launches A New Division - Bioo TherapeuticsAdd Pharma/BioTech/Nutrition News to My MSNAdd Pharma/BioTech/Nutrition News to My Yahoo!Add NewswireToday Pharma/BioTech/Nutrition Press Release Headline News to Your Google homepage or Google ReaderAdd NewswireToday - PRZOOM Headline News to FeedBurner Twitter /NewswireToday

This article was published free of charge. Only PREMIUM Articles are (Google AdSense™) 3rd party Ads-Free!


Read Latest Articles From Bioo Scientific / Company Profile



Bioo Scientific Launches Two New MaxSignal® Aflatoxin M1 ELISA Kits
MaxSignal® Malachite Green/LMG ELISA Now Included in the USDA’s Chemistry Laboratory Guidebook
NEXTflex™ Modules Lower the Cost of Next Generation Sequencing Sample Prep
Bioo Scientific Simplifies the Analysis of Apoptotic Bodies with the D-Pop™ Kit
Bioo Scientific and Jungwoo F&B to Collaborate to Improve Cancer Diagnosis and Treatment
Bioo Scientific Will Participate in the 2011 AOAC International Annual Meeting
Dr. Masoud Toloue will Describe Methyl-Seq and Small RNA-Seq NGS Library Prep Technologies
Dr Joe Krebs Will Lecture About Melamine Detection in Food At the AOAC Pacific NW Annual Meeting
Bioo Scientific Honored with Export Award
NEXTflex Small RNA Sequencing Kit for NGS Library Prep Launched
Bioo Scientific Launched the AIR™ DNA Fragmentation Kit for Genomic DNA Fragmentation
Bioo Scientific Presented Validation Studies at the Intl Food Safety Conference in Jakarta Indonesia
Bioo Scientific’s New NEXTflex™ Kits Remove PCR Amplification from NGS Library Prep Reducing Bias
Bioo Scientific Launches a Sensitive ELISA for Detection of Melamine Contamination in Food
Bioo Scientific Awarded Funding from NSF for the Biomolecular Detection of miRNA

Reserve This Permanent SPACE

Your LOGO permanently HERE on Newswire Today most visited Page start at $295 per month

 
Sponsored Links


Visit  Koncept Analytics

Visit  NAMSR - National Assoc. of Medical Sales Rep










 
  ©2012 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise | Contact | Investors | Sitemap | FRANCAIS
newswire, PR free press releases distribution magazines engine news alert newsroom press room breaking news public relations articles company news alerts blogsIt younews.me newswiredistribution ezine younews.asia bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri- bution today investor relation successful internet entrepreneur free newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)